Alphabetical Checklist of Dosages and Uses of 100 Common Psychotropic Medications Usual Adult Daily Dosage FDA-approved Common “Off-label” Range in mgs Indication(s) Uses, if any Xanax, XR alprazolam, ODT Niravam D- & L-amphetamine Adderall, XR Strattera Cogentin buprenorphine & naloxoneSuboxoneOpioid antagonist Wellbutrin/Zyban BudeprionER Tegretol carbamazepine ER Equetro chlordiazepoxide Librium Anafranil Klonopin, Wafers Tranxene Catapres Clozaril/FazaClo dexmethylphenidate Focalin, XR dextroamphetamine Dexedrine Antabuse Depakote/-ene/-con Sinequan/Adapin Cymbalta
MDD, Neuropathic Pain Depr, GAD, PmDD, PTSD, SocAnxProzac/Sarafem Neurontin Razadyne Tofranil/PM Lamictal lithium carbonate Eskalith/Lithobid Ludiomil methamphetamine Desoxyn methylphenidate Concerta methylphenidateDaytrana methylphenidate Metadate methylphenidate Methylin methylphenidate Ritalin Remeron/Soltab Provigil Vivitrol naltrexone/nalmefene Revia/Revex [Serzone] Aventyl/Pamelor Zyprexa/Zydis olanzapine & fluoxetine Symbyax Trileptal Paxil/Pexeva Kemadrin Anx, Alch withdrl, Akathisia, PanicSeroquel Risperdal Eldepryl Restoril Gabitril Effexor, XR Ambien, CR Zonegran We have other “Tools for Busy Clinicians” at www.ThreeWishesPress.com. Need the now-required ICD-9 Diagnoses? All clinicians have to get a National Provider Identifier number by 5/23/07: Learn how. Be knowlegable not just compliant with HIPAAHelp. An updated version of this list will be posted about every three months at www.psychmeds.info Drug Class Abbreviations: Antidyskinetic = drugs used to treat Parkinson’s disease and extrapyramidal effects of antipsychotics. Anorexient = to treat obesity. Atypical = newer antipsychotics/neuroleptics. The Conventional, older antipsychotics/neuroleptics are now rarely used and so are not listed. DNRI = Dopamine-
Norepinephrine Reuptake Inhibitor. MAOI = Monoamine Oxidase Inhibitor. NRI = Norepinephrine Reuptake Inhibitor. PDE-5 inhibitor= Phosphodiesterase type-5 inhibitors. SARI = Serotonin-2 antagonist/Serotonin Reuptake Inhibitor. SNRI = Serotonin-Norepinephrine Reuptake Inhibitor. SSRI = Selective Serotonin Reuptake Inhibitor. TetracyclicAD = Tetracyclic Antidepressant. TricyclicAD = Tricyclic Antidepressants almost replaced by SSRIs and so few listed. [ ] = drug withdrawn by manufacturer but
still available as generic. Removed from the market. ODT = Orally Disintegrating Tablet. Indications and Disorder Abbreviations: ADHD = Attention Deficit Hyperactivity Disorder.Anorexiant = For exogenous obesity. Anx = Anxiety Disorder NOS. BDD =
Body Dysmorphic Disorder. Bipolar = Bipolar Affective Disorder (antimanic). Depr = Depression (see MDD). DFA =Difficulty Falling Asleep.Eat = Eating Disorders. EDS =
Excessive Daytime Sleepiness. EMA = Early Morning Awakening. GAD = Generalized Anxiety Disorder. Hypn = Hypnotic (sleep inducer) for many sleep disorders. MDD =
Major Depressive Disorder (not Dysthymia or Depression NOS).Narco = Narcolepsy.NeuroPath Pain = Neuropathic pain associated with diabetic peripheral neuropathy. OSA = Obstructive Sleep Apnea. OCD = Obsessive-Compulsive Disorder. Panic = Panic Disorder, with or without Agoraphobia. Phob = Phobia.PmDD = Premenstrual
Dysphoric Disorder. PTSD = Post-Traumatic Stress Disorder. SAD = Seasonal Affective Disorder. Schizophrenia = Schizophrenia, Psychosis, and related conditions. SCD
= Sleep Continuity Disturbance. SWSD = Shift Work Sleep Disorder:SocAnx = Social Anxiety /Social Phobia. Disclaimer: The information presented here is intended as general health information and as an educational tool but is not precise enough for making prescribing
decisions and is not to be construed as medical advice. The indications/diagnoses are not exclusive, exhaustive, or precise. We have tried to be accurate but errors may
exist here. Listing here is in no sense an endorsement by the authors of the use of any medication for any treatment purpose. The dosages offered here are for maintenance
and authorities differ on these. Starting doses may be lower and for some people higher dosages (supra-therapeutic) are warranted. All trade and generic names are the
property of their respective manufacturers, distributors, and copyright holders. Non-commercial copying and distribution of this list is permitted as long as NO changes are made to it. Any other uses require written permission. Copyrighted 2004-2006 by Edward Zuckerman and Dan Egli.
Discovery Labs Releases New AFECTAIRTM Performance Data Presented at the American Association for Respiratory Care Annual Meeting Company Releases First in Series of Studies Supporting New Product Candidate WARRINGTON, PA – November 8, 2011 — Discovery Laboratories, Inc. (Nasdaq: DSCO) today announced that new data supporting AFECTAIRTM, the Company’s newest product can
Landelijke commissie infectieziektebestrijding Bij opgravingen in duizend jaar oude Vikingnederzettingen in Groenland werden in de resten al luizen aangetroffen. Maar hoofdluis lijkt een nog veel ouder probleem. De derde Bijbelse plaag wordt in de oorspronkelijke teksten 'luizen' genoemd. Hoofdluis komt vooral bij jonge kinderen voor (tussen drie en twaalf jaar) en vormt op lagere scholen